A Look at the History of Biosimilar Adoption: Characteristics of Early and Late Adopters of Infliximab and Etanercept Biosimilars in Subregions of England, Scotland and Wales - A Mixed Methods Study
ConclusionsThis study has shown that the savings potential drives biosimilar use. Regions with a proactive attitude, good stakeholder relationships, and clinician engagement were identified as early adopters.
Source: BioDrugs - Category: Drugs & Pharmacology Source Type: research
More News: Drugs & Pharmacology | Enbrel | History of Medicine | Remicade | Scotland Health | Study | UK Health | Wales Health